Development and Clinical Application of Anti-Her2 Monoclonal and Bispecific Antibodies for Cancer Treatment
Experimental Hematology and Oncology - United Kingdom
doi 10.1186/s40164-017-0091-4
Full Text
Open PDFAbstract
Available in full text
Date
November 28, 2017
Authors
Publisher
Springer Science and Business Media LLC